Su Chen

2.4k total citations
86 papers, 1.5k citations indexed

About

Su Chen is a scholar working on Molecular Biology, Rheumatology and Surgery. According to data from OpenAlex, Su Chen has authored 86 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Rheumatology and 12 papers in Surgery. Recurrent topics in Su Chen's work include Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Su Chen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Su Chen collaborates with scholars based in China, United States and Germany. Su Chen's co-authors include Gregg Staerkel, Yun Gong, Ming Guo, Beng Chin Ooi, John Stewart, Aileen L. Pangan, Ronald van Vollenhoven, Mohamed‐Eslam F. Mohamed, Tsutomu Takeuchi and Alan Friedman and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Su Chen

78 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Chen China 21 520 323 311 303 245 86 1.5k
Ryu Watanabe Japan 28 967 1.9× 987 3.1× 522 1.7× 309 1.0× 1.1k 4.4× 125 2.7k
Yun Cao China 27 189 0.4× 341 1.1× 802 2.6× 398 1.3× 267 1.1× 127 2.3k
Bing Liu China 25 108 0.2× 236 0.7× 946 3.0× 625 2.1× 365 1.5× 136 2.4k
Kenji Oku Japan 24 1.2k 2.3× 211 0.7× 193 0.6× 60 0.2× 566 2.3× 103 2.0k
G Kolarz Austria 21 556 1.1× 108 0.3× 232 0.7× 93 0.3× 106 0.4× 94 1.2k
Victor Wei Zhang China 33 138 0.3× 195 0.6× 1.7k 5.6× 139 0.5× 257 1.0× 170 3.3k
E Ascari Italy 30 164 0.3× 195 0.6× 657 2.1× 397 1.3× 298 1.2× 172 2.8k
Abhijit Ghosh United States 22 179 0.3× 265 0.8× 252 0.8× 76 0.3× 94 0.4× 68 1.3k
Noriaki Sakamoto Japan 18 52 0.1× 272 0.8× 191 0.6× 196 0.6× 96 0.4× 118 1.2k
Xiaoli Cui China 20 37 0.1× 251 0.8× 541 1.7× 309 1.0× 100 0.4× 89 1.6k

Countries citing papers authored by Su Chen

Since Specialization
Citations

This map shows the geographic impact of Su Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Chen more than expected).

Fields of papers citing papers by Su Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Chen. The network helps show where Su Chen may publish in the future.

Co-authorship network of co-authors of Su Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Su Chen. A scholar is included among the top collaborators of Su Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Chen. Su Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Su, Jianhan Lin, Cong Li, et al.. (2025). Tumor-specific liquid metal nitric oxide nanogenerator for enhanced breast cancer therapy. Asian Journal of Pharmaceutical Sciences. 20(2). 101018–101018. 1 indexed citations
2.
Chen, Su, et al.. (2024). Histone Lysine Lactylation (Kla)‐induced BCAM Promotes OSCC Progression and Cis‐Platinum Resistance. Oral Diseases. 31(4). 1116–1132. 8 indexed citations
3.
4.
Miao, Jie, et al.. (2024). Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies. Molecular Neurobiology. 62(3). 3195–3225. 13 indexed citations
5.
6.
Chen, Su, et al.. (2024). Primary mediastinal Ewing’s sarcoma presenting with sudden and severe chest pain: a case report. Frontiers in Oncology. 13. 1290603–1290603.
7.
Huang, Guangzhao, et al.. (2023). Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway. International Journal of Molecular Sciences. 24(3). 1992–1992. 15 indexed citations
8.
Panaccione, Remo, Silvio Danese, Wen Zhou, et al.. (2023). Efficacy and safety of upadacitinib for 16‐week extended induction and 52‐week maintenance therapy in patients with moderately to severely active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 59(3). 393–408. 16 indexed citations
9.
Qin, Jun, et al.. (2023). Prediction and Mechanisms of Spontaneous Resorption in Lumbar Disc Herniation: Narrative Review. Spine Surgery and Related Research. 8(3). 235–242. 5 indexed citations
10.
Zhang, Zhenhua, et al.. (2023). Chlorophyll and POC in polar regions derived from spaceborne lidar. Frontiers in Marine Science. 10. 10 indexed citations
11.
12.
Xu, Shaohua, Hui Liu, Jiahui Xie, et al.. (2022). Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients. Frontiers in Oncology. 12. 970613–970613. 2 indexed citations
13.
Li, Yuan, et al.. (2021). Biphalin, a dimeric opioid peptide, reduces neonatal hypoxia-ischemia brain injury in mice by the activation of PI3K/Akt signaling pathway. Journal of Chemical Neuroanatomy. 115. 101967–101967. 5 indexed citations
14.
Elewaut, Dirk, Jürgen Braun, J. Anderson, et al.. (2020). Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases. Arthritis Care & Research. 73(2). 289–295. 6 indexed citations
15.
Kloppenburg, M., Charles Peterfy, I.K. Haugen, et al.. (2018). Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Annals of the Rheumatic Diseases. 78(3). 413–420. 130 indexed citations
16.
Wang, Tingting, et al.. (2018). ECNU at 2018 eHealth Task 2: Technologically Assisted Reviews in Empirical Medicine.. CLEF (Working Notes). 4 indexed citations
17.
Chen, Jiayi, Su Chen, Yang Song, et al.. (2017). ECNU at 2017 eHealth Task 2: Technologically Assisted Reviews in Empirical Medicine.. CLEF (Working Notes). 4 indexed citations
18.
Landewé, Robert, Josef S Smolen, S. Florentinus, et al.. (2015). Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 133–133. 11 indexed citations
19.
Chen, Su, Jian Jiao, Zongmiao Wan, et al.. (2015). T-box transcription factor Brachyury in lung cancer cells inhibits macrophage infiltration by suppressing CCL2 and CCL4 chemokines. Tumor Biology. 36(8). 5881–5890. 9 indexed citations
20.
Chen, Su. (1998). SOME RESULTS ON CLT FOR NONSTAIONARY NA SEQUENCES. Acta Mathematicae Applicatae Sinica English Series. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryu Watanabe Breakdown of academic impact, for papers by Yun Cao Breakdown of academic impact, for papers by Bing Liu Breakdown of academic impact, for papers by Kenji Oku Breakdown of academic impact, for papers by G Kolarz Breakdown of academic impact, for papers by Victor Wei Zhang Breakdown of academic impact, for papers by E Ascari Breakdown of academic impact, for papers by Abhijit Ghosh Breakdown of academic impact, for papers by Noriaki Sakamoto Breakdown of academic impact, for papers by Xiaoli Cui
Rankless by CCL
2026